Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYOV | MRUS | JANX | ||
| Company | Myovant Sciences Ltd | Merus N.V. CS | Janux Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 26.99 | 44.66 | 47.08 | ||
| High | 27.00 | 45.84 | 48.23 | ||
| Low | 26.98 | 44.00 | 46.51 | ||
| Last | 26.98 | 45.04 | 47.39 | ||
| Change | -0.01 | +0.11 | +0.29 | ||
| % Change | -0.04% | +0.24% | +0.62% | ||
| Volume | 2,256,000 | 822,900 | 573,900 | ||
| 20-Day Average Volume | 1,234,240 | 605,320 | 852,960 | ||
| Previous Close | 26.99 | 44.93 | 47.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.95 | 42.69 | 44.78 | ||
| 20-Day Raw Stochastic | 50.00% | 80.69% | 58.96% | ||
| 20-Day Relative Strength | 61.08% | 56.83% | 62.30% | ||
| Weighted Alpha | +96.20 | +132.82 | -31.54 | ||
| Today's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 64% Buy | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 80% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 03/02/23 | +13.14% since 04/19/24 | -2.67% since 04/19/24 | ||
| Low | 26.95 on 03/06/23 | 39.93 on 04/22/24 | 44.71 on 04/22/24 | ||
| High | 27.00 on 03/09/23 | 45.84 on 04/26/24 | 50.42 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +0.30% since 02/09/23 | +0.29% since 03/26/24 | +22.01% since 03/26/24 | ||
| Low | 26.90 on 02/13/23 | 39.27 on 04/19/24 | 34.63 on 04/05/24 | ||
| High | 27.06 on 02/13/23 | 46.42 on 04/04/24 | 56.27 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | +0.71% since 12/09/22 | +32.31% since 01/26/24 | +407.93% since 01/26/24 | ||
| Low | 26.75 on 12/16/22 | 33.83 on 01/29/24 | 7.79 on 02/05/24 | ||
| High | 27.06 on 02/13/23 | 52.03 on 03/01/24 | 58.69 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +36.13% since 09/09/22 | +119.60% since 10/26/23 | +661.90% since 10/26/23 | ||
| Low | 16.26 on 09/23/22 | 19.81 on 10/30/23 | 5.65 on 11/10/23 | ||
| High | 27.06 on 02/13/23 | 52.03 on 03/01/24 | 58.69 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,623,400 | 2,643,307 | 2,448,167 | ||
| Shares Outstanding, K | 97,235 | 58,688 | 51,660 | ||
| Annual Sales | 230,970,000 | 43,950,000 | 8,080,000 | ||
| Annual Net Income | -205,980,000 | -154,940,000 | -58,290,000 | ||
| Last Quarter Sales | 100,230,000 | 8,940,000 | 2,460,000 | ||
| Last Quarter Net Income | -57,630,000 | -60,150,000 | -11,760,000 | ||
| 60-Month Beta | 2.17 | 1.10 | 4.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 01/26/23 | -1.09 on 02/28/24 | -0.25 on 03/08/24 | ||
| Latest Earnings Date | 01/25/23 | 05/02/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||